Clinical Trial

Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

Name: Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke — clinical trial record (NCT05686642)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This phase II clinical study is designed to evaluate the safety and efficacy of LT3001 in the treatment of acute ischemic stroke

Protocol Amendment History 27 amendments

This ClinicalTrials.gov record has been amended 27 times since 2023-01-09; most recent amendment 2026-04-29.

Status change: Not Yet Recruiting → Recruiting 2023-04-07

Trial Details

NCT Number	NCT05686642
Lead Sponsor	Shanghai Pharmaceuticals Holding Co., Ltd
Conditions	Acute Ischemic Stroke
Enrollment	300 participants
Start Date	2023-04-06
Primary Completion	2026-12-10 (estimated)
Study Completion	2026-12-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-30